Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where K. Aertgeerts is active.

Publication


Featured researches published by K. Aertgeerts.


FEBS Letters | 1997

IDENTIFICATION OF POSITIVELY CHARGED RESIDUES CONTRIBUTING TO THE STABILITY OF PLASMINOGEN ACTIVATOR INHIBITOR 1

Ann Gils; Jie Lu; K. Aertgeerts; I Knockaert; Paul Declerck

Plasminogen activator inhibitor 1 (PAI‐1), a member of the serpins, has a unique conformational flexibility. A typical characteristic is its intrinsic lability resulting in the conversion of the active conformation to a latent conformation. In the present study, we have evaluated the effect of substitution of positively charged residues located at the turn connecting strand s4C with strand s3C, either with negatively charged or with neutral residues, on the functional stability of PAI‐1. The following mutants were constructed, purified and characterized in comparison to wild‐type (wt) PAI‐1: PAI‐1‐R186E,R187E (Arg186→Glu and Arg187→Glu), PAI‐1‐H190E,K191E (His190→Glu and Lys191→Glu) and PAI‐1‐H190L,K191L (His190→Leu and Lys191→Leu). In contrast to wtPAI‐1 the mutants exhibited no inhibitory activity. Whereas latent wtPAI‐1 can be reactivated (up to a specific activity of 78±19%) by treatment with guanidinium chloride, a similar treatment applied to these mutants resulted in a significant but relatively small increase of specific activity (i.e. to 14%). Evaluation of the functional stability (at 37°C, pH 5.5, 1 M NaCl) revealed a strongly decreased functional stability compared to wtPAI‐1 (i.e. 3–9 h for the mutants vs. >24 h for wtPAI‐1). Further characterization by heat denaturation studies and plasmin susceptibility confirmed that removal or reversal of the positive charge on the turn connecting s4C with s3C results in PAI‐1 mutants with a highly accelerated conversion of active to latent forms. We can therefore conclude that the pronounced positive charge in the turn connecting s4C with s3C is of the highest importance for the functional stability of PAI‐1.


Fibrinolysis and Proteolysis | 1999

Induction of conformational changes within crystals of plasminogen activator inhibitor-1 (PAI-1)

Pka Willems; Ann Gils; K. Aertgeerts; C. J. De Ranter; Paul Declerck

Abstract Plasminogen activator inhibitor-1 (PAI-1) is a member of the serpin (serine protease inhibitor) superfamily, that can adopt three different conformations: active, latent and substrate. It was recently shown that the non-ionic detergent Triton X-100 (TX-100) can accelerate the conformational transitions in wild-type PAI-1 in solution. Recently, we have crystallized a stable PAI-1 variant (PAI-1-stab) in its active conformation (Acta Cryst D 55, 574–576, 1999). In this study, we examined the effect of TX-100 on the conformational transitions in PAI-1-stab, in solution as well as in crystals. Within the crystal (at t = 0: 75 ± 3% active, 10 ± 4% non-reactive and 15 ± 4% substrate; mean ± SD, n = 3) a time-dependent increase of the substrate form was observed, with a concomitant decrease of the active form. A steady state situation with active (52 ± 2%) and substrate (34 ± 5%) forms was reached within 4 h. Under those conditions, the amount of non-reactive PAI-1 remained essentially unchanged (14 ± 5%). The conformational changes induced by TX-100 in PAI-1-stab in solution (at t = 0: 59 ± 2% active, 0% non-reactive and 41 ± 2% substrate, n = 3) were characterized mainly by a decrease of the active form in favour of the non-reactive form, reaching a steady state between 15 and 24 h resulting in active (20 ± 3%, n = 4), substrate (29 ± 3%) and non-reactive (48 ± 5%) forms. Thus, this study demonstrates that, even though characterized with a restricted mobility, conformational changes can be induced within protein crystals. Importantly, in both cases studied a steady state situation with various functional forms was observed.


Acta Crystallographica Section D-biological Crystallography | 1999

Plasminogen activator inhibitor 1 (PAI-1) in its active conformation: crystallization and preliminary X-ray diffraction data

Pka Willems; Anja Rabijns; K. Aertgeerts; Nele Vleugels; I Knockaert; H.L. De Bondt; C. J. De Ranter; Paul Declerck

Because of its intrinsic lability, wild-type plasminogen activator inhibitor 1 (PAI-1) cannot be crystallized in its active conformation. Therefore, a stable variant of PAI-1 was used to retain the active conformation during crystallization. Four different crystallization conditions were evaluated in detail and two major types of crystals were detected. Whereas solutions consisting of either (i) cacodylate and sodium acetate, (ii) lithium sulfate and polyethylene glycol 4K, or (iii) imidazole, sodium chloride and sodium potassium phosphate buffer revealed thin platelet crystals, a solution (iv) containing ammonium acetate, citrate and polyethylene glycol 4K appeared to enhance the formation of clustered brush-like crystals. Crystals grown under condition (iii) were found to be suitable for X-ray data collection and consequent structural investigation. Data collection was 79.8% complete with a maximum resolution of 2.92 A. Importantly, PAI-1 retained its functional properties under all conditions.


Nature Structural & Molecular Biology | 1995

Mechanisms contributing to the conformational and functional flexibility of plasminogen activator inhibitor-1.

K. Aertgeerts; Hendrik L. De Bondt; Camiel J. De Ranter; Paul Declerck


Journal of Structural Biology | 1994

A model of the reactive form of plasminogen activator inhibitor-1.

K. Aertgeerts; H.L. De Bondt; C. J. De Ranter; Paul Declerck


Proteins | 1995

Crystallization and X-ray diffraction data of the cleaved form of plasminogen activator inhibitor-1

K. Aertgeerts; H.L. De Bondt; C. J. De Ranter; Paul Declerck


Journal of Structural Biology | 1997

Rational Design of Complex Formation between Plasminogen Activator Inhibitor-1 and Its Target Proteinases

K. Aertgeerts; Camiel J. De Ranter; Nuala A. Booth; Paul Declerck


Thrombosis and Haemostasis | 1995

Crystal-structure of a cleaved variant of human plasminogen-activator inhibitor-1

K. Aertgeerts; Hl Debondt; C Deranter; Paul Declerck


Thrombosis and Haemostasis | 1999

Induction of conformational changes within crystals of plasminogen activator inhibitor-1

Pka Willems; Ann Gils; K. Aertgeerts; C. J. De Ranter; Paul Declerck


Archive | 1999

CLEAVED SUBSTRATE VARIANT OF PLASMINOGEN ACTIVATOR INHIBITOR-1

K. Aertgeerts; H.L. De Bondt; C. J. De Ranter; Paul Declerck

Collaboration


Dive into the K. Aertgeerts's collaboration.

Top Co-Authors

Avatar

Paul Declerck

Katholieke Universiteit Leuven

View shared research outputs
Top Co-Authors

Avatar

C. J. De Ranter

Katholieke Universiteit Leuven

View shared research outputs
Top Co-Authors

Avatar

H.L. De Bondt

Katholieke Universiteit Leuven

View shared research outputs
Top Co-Authors

Avatar

Ann Gils

Katholieke Universiteit Leuven

View shared research outputs
Top Co-Authors

Avatar

Pka Willems

Katholieke Universiteit Leuven

View shared research outputs
Top Co-Authors

Avatar

Camiel J. De Ranter

Katholieke Universiteit Leuven

View shared research outputs
Top Co-Authors

Avatar

I Knockaert

Katholieke Universiteit Leuven

View shared research outputs
Top Co-Authors

Avatar

Anja Rabijns

Katholieke Universiteit Leuven

View shared research outputs
Top Co-Authors

Avatar

Hendrik L. De Bondt

Katholieke Universiteit Leuven

View shared research outputs
Top Co-Authors

Avatar

Jie Lu

Katholieke Universiteit Leuven

View shared research outputs
Researchain Logo
Decentralizing Knowledge